🇺🇸 FDA
Pipeline program

Ketamine

NMCSD.2011.0063

Phase 1 small_molecule terminated

Quick answer

Ketamine for Acute Depression is a Phase 1 program (small_molecule) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
Acute Depression
Phase
Phase 1
Modality
small_molecule
Status
terminated

Clinical trials